Ajay Sheshadri, MD, MSCI, Associate Professor Department of Pulmonary Medicine The University of Texas MD Anderson Cancer Center
Ryan M. Weight DO, MS, Medical Director The Melanoma And Skin Cancer Institute Denver, CO
Learning Objectives
At the end of this educational program, participants should be able to:
Apply evidence-based practices for the monitoring and management of immune-related adverse events (irAE) in patients receiving cancer immunotherapies
Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies
Click here to learn about remaining Project ECHO sessions or to view other available recordings.